Skip to main content
. 2015 Nov 21;21(43):12274–12282. doi: 10.3748/wjg.v21.i43.12274

Table 4.

Aberrant microRNA expression in human peripheral blood in Crohn’s disease

Status Tissue type Control Aberrant microRNA expression Ref.
Active CD Peripheral blood, n = 14 Healthy Decreased: miR-149* and plus-F1065 Wu et al[31], 2011
Increased: miR-199a-5p, 340*, 362-3p, 532-3p and plus-E1271
Peripheral blood, n = 46 Healthy Increased: miR-16, 20a, 21, 30e, 93, 106a, 140, 192, 195, 484 and let-7b Zahm et al[33], 2011
Peripheral blood, n = 128 Healthy Increased: miR-16, 23a, 29a, 106a, 107, 126, 191, 199a-5p, 200c, 362-3p and 532-3p Paraskevi et al[32], 2012
Active and inactive CD Peripheral blood, n = 18 Healthy Decreased: miR-877 Iborra et al[25], 2013
Increased: miR-16, 27a*, 140-3p, 140-5p and 195
Inactive CD Peripheral blood, n = 5 Healthy Decreased: miR-149* Wu et al[31], 2011
Increased: miR-340*
Active CD Peripheral blood, n = 9 Inactive CD Decreased: miR-18a, 128, 140-5p and 145 Iborra et al[25], 2013
Increased: miR-188-5p and 877

CD: Crohn’s disease; UC: Ulcerative colitis.